Verapamil as Therapy for Children and Young Adults With Dravet Syndrome

Completed · Phase 2

Conditions studied: Dravet Syndrome

In brief

This study will assess how well the drug verapamil can improve control of seizures and dysautonomia symptoms in children and young adults diagnosed with Dravet syndrome. The safety of verapamil when given with all concomitant medications will also be assessed.

Key facts

Study ID
NCT01607073
Run by
Gillette Children's Specialty Healthcare
People needed
2
Starts
2012-04-01
Expected to finish
2015-01-01
Last updated by the study team
2021-04-13

Who can join

Age: 2 and older, up to 25. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.